RSS Feeds
Search

Companies

Companies

Displaying 1..2 of 2 - per page
Order by
Profiled on pharmalicensing.com CrystecPharma
CrystecPharma applies the latest supercritical fluid (SCF) technologies to improve the design and performance of medicines More
Decision Resources Inc.
The worldwide leader in market research publications, advisory services and consulting More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011 - 4 pages - $500
Liver Fibrosis Global Clinical Trials Review, Q1, 2011
Apr 2011 - 57 pages - $1,000
Liver Fibrosis Global Clinical Trials Review, H2, 2011
Sep 2011 - 83 pages - $1,000
Liver Fibrosis - Pipeline Review, Q4 2010
Dec 2010 - 29 pages - $500
Marien-Hospital Wesel GmbH - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010
Dec 2010 - 52 pages - $1,000
Cystic Fibrosis Therapy Area Pipeline Report
Nov 2010 - 176 pages - $1,495
Pulmonary Fibrosis Therapy Area Pipeline Report
Nov 2010 - 115 pages - $1,495
Cystic Fibrosis – Pipeline Assessment and Market Forecasts to 2017
Aug 2010 - 49 pages - $2,000
Union Memorial Hospital - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us